Inflazome Limited

Irlande


Commandez votre montre hebdomadaire Inflazome Limited
Quantité totale PI 85
Rang # Quantité totale PI 15 891
Note d'activité PI 2,6/5.0    52
Rang # Activité PI 13 844
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

39 0
2 0
40 2
2
 
Dernier brevet 2025 - Novel sulfonamide carboxamide co...
Premier brevet 2018 - Novel sulfonamide carboxamide co...
Dernière marque 2017 - INFLAZOME
Première marque 2016 - INFLAZOME

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Novel sulfonamide carboxamide compounds. The present invention relates to compounds of formula (...
Invention Compounds. The present invention relates to phenylsulfonylureas and phenylsulfonylthioureas, whe...
2022 Invention Sulfonamide carboxamide compounds. 3.
2021 Invention Sodium salt of n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl) carbamoyl) -1 -isopropyl-1 h-pyrazole-3-...
Invention Compounds. The present invention relates to macrocyclic compounds, such as macrocyclic sulfonyl ...
Invention Compounds. The present invention relates to macrocyclic compounds, such as macrocyclic sulfonyl t...
2020 Invention Treatment and prevention of neuroinflammation or an inflammatory brain disorder. The present inv...
Invention Treatment of autoinflammatory disorders. The present invention relates to a compound of formula ...
Invention Treatment and prevention of a neurodegenerative disorder. The present invention relates to a com...
Invention Treatment of arthritis. The present invention relates to a compound of formula (I) for use in th...
Invention Treatment and prevention of a traumatic brain disorder. The present invention relates to a compou...
Invention Treatment or prevention of psychiatric brain disorders using the nlrp3 inhibitor n-((1,2,3,5,6,7-...
Invention Treatment of autoinflammatory disorders. The present invention relates to a compound of formula (...
Invention Treatment of arthritis. The present invention relates to a compound of formula (I) for use in the...
Invention Treatment and prevention of a neurodegenerative disorder. The present invention relates to a comp...
Invention Treatment and prevention of neuroinflammation or an inflammatory brain disorder. The present inve...
Invention Nlrp3 inhibitors. The present invention relates to substituted5-membered nitrogen containing het...
Invention Nlrp3 inhibitors. 533inhibition.
Invention Macrocyclic sulfonylamide derivatives useful as nlrp3 inhibitors. The present invention relates ...
Invention Macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitors. The present invention relates t...
Invention Macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitors. 33 inhibition.
Invention Macrocyclic sulfonylamide derivatives useful as nlrp3 inhibitors. 33 inhibition.
Invention Nlrp3 inflammasome inhibition. The present invention relates to a binding site of the NLRP3 infl...
Invention Nlrp3 inflammasome inhibition. 333333 inflammasome, and to a compound identified by such a screen...
2019 Invention Nlrp3 inhibitors. The present application relates to compounds with NLRP3inhibitory activity and...
Invention Processes. The present invention relates to processes of preparing N-((1,2,3,4,5,6,7-hexahydro-s-...
Invention Sulfonamideurea compounds. 2 may optionally be further substituted. The present invention further...
Invention Novel sulfoneurea compounds. The present invention relates to compounds of formula (I): wherein ...
Invention Novel compounds. The present invention relates to substituted 5-membered nitrogen containing het...
Invention Compounds. The present invention relates to sulfonylureas and sulfonylthioureas of formula (I) co...
Invention Phenylsulfonylurea derivatives useful as nlrp3 inhibitors. The present invention relates to phen...
Invention Compounds. 4 alkyl group. The present invention further relates to salts, solvates and prodrugs o...
Invention Compounds. The present invention relates to compounds of formula (I): comprising a 5-membered nit...
Invention Sulfonyl acetamides as nlrp3 inhibitors. 4 alkyl. The present invention further relates to salts,...
Invention Sulfonamide derivates as nlrp3 inhibitors. 3.
Invention Novel compounds. The present invention relates to compounds of formula (I): wherein Q is selecte...
Invention Sulfonyl acetamides as nlrp3 inhibitors. 3.
2018 Invention Sulfonamide carboxamide compounds. The present invention relates to sulfonylureas and sulfonylthi...
Invention Compounds. 3.
Invention 3 inhibitors. 3.
Invention Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors. 3.
Invention Novel sulfonamide carboxamide compounds. The present invention relates to sulfonylureas and sulf...
Invention Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors. The present invention relates to sulfony...
Invention Sulfonamide carboxamide compounds. The present invention relates to compounds of formula (I): 2 ...
Invention Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors. The present invention relates to compoun...
2017 P/S Chemical and reagents for scientific use; chemical diagnostic reagent for industrial use. Medica...
P/S Chemical and reagents for scientific use; chemical diagnostic reagent for industrial use. Diagno...
2016 P/S Chemical and reagents for scientific use; chemical diagnostic reagent for industrial use. Diagnos...
P/S Chemical and reagents for scientific use; chemical diagnostic reagent for industrial use. Medical...